130 related articles for article (PubMed ID: 10155709)
1. Evidence for proteolytic cleavage of covalently bound protein A from a silica based extracorporeal immunoadsorbent and lack of relationship to treatment effects.
Balint JP; Jones FR
Transfus Sci; 1995 Mar; 16(1):85-94. PubMed ID: 10155709
[TBL] [Abstract][Full Text] [Related]
2. Specificity of antibody responses affected by extracorporeal immunoadsorption of plasma over columns of protein A silica.
Snyder HW; Seawell BW; Cochran SK; Balint JP; Jones FR
J Clin Apher; 1992; 7(3):110-8. PubMed ID: 1337544
[TBL] [Abstract][Full Text] [Related]
3. A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.
Fennelly DW; Norton L; Sznol M; Hakes TB
Cancer; 1995 Apr; 75(8):2099-102. PubMed ID: 7697600
[TBL] [Abstract][Full Text] [Related]
4. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma.
Snyder HW; Mittelman A; Oral A; Messerschmidt GL; Henry DH; Korec S; Bertram JH; Guthrie TH; Ciavarella D; Wuest D
Cancer; 1993 Mar; 71(5):1882-92. PubMed ID: 8448753
[TBL] [Abstract][Full Text] [Related]
5. The use of protein A columns in the treatment of cancer and allied diseases.
Ciavarella D
Int J Clin Lab Res; 1992; 21(3):210-3. PubMed ID: 1591370
[TBL] [Abstract][Full Text] [Related]
6. Modulation of idiotypic and antiidiotypic immunoglobulin G responses in an immune thrombocytopenic purpura patient as a consequence of extracorporeal protein A immunoadsorption.
Balint JP; Cochran SK; Jones FR
Artif Organs; 1995 Jun; 19(6):496-9. PubMed ID: 8526787
[TBL] [Abstract][Full Text] [Related]
7. Association of anti-platelet IgG antibody levels with response to extracorporeal protein A/silica immunoadsorption in ITP patients.
Balint JP; Quagliata F; Cochran SK; Jones FR
Am J Hematol; 1995 Sep; 50(1):74-5. PubMed ID: 7668242
[No Abstract] [Full Text] [Related]
8. Heparin-induced coagulopathy associated with staphylococcal protein A immunoadsorption treatment columns: an in vitro and in vivo analysis.
Kunkel JF; Sarode R; Verba M; Yomtovian R
Transfusion; 2000 Jun; 40(6):697-701. PubMed ID: 10864991
[TBL] [Abstract][Full Text] [Related]
9. Reduction in platelet-binding immunoglobulins and improvement in platelet counts in patients with HIV-associated idiopathic thrombocytopenia purpura (ITP) following extracorporeal immunoadsorption of plasma over staphylococcal protein A-silica.
Snyder HW; Bertram JH; Channel M; Ernst NR; Balint JP; Jones FR
Artif Organs; 1989 Feb; 13(1):71-7. PubMed ID: 2540735
[TBL] [Abstract][Full Text] [Related]
10. Treatment of patients with HIV thrombocytopenia and hemolytic uremic syndrome with protein A (Prosorba column) immunoadsorption.
Mittelman A; Bertram J; Henry DH; Snyder HW; Messerschmidt GL; Ciavarella D; Ainsworth S; Kiprov D; Arlin Z
Semin Hematol; 1989 Apr; 26(2 Suppl 1):15-8. PubMed ID: 2658095
[TBL] [Abstract][Full Text] [Related]
11. Background and indications for protein A-based extracorporeal immunoadsorption.
Matic G; Bosch T; Ramlow W
Ther Apher; 2001 Oct; 5(5):394-403. PubMed ID: 11778926
[TBL] [Abstract][Full Text] [Related]
12. Selective removal of antigen-complexed IgG from cat plasma by adsorption onto a protein A-silica matrix.
Snyder HW; Ernst NR; Grosmaire LS; Balint JP; Yoshida LH; Jones FR
J Immunol Methods; 1987 Aug; 101(2):209-17. PubMed ID: 3039006
[TBL] [Abstract][Full Text] [Related]
13. Immune modulation associated with extracorporeal immunoadsorption treatments utilizing protein A/silica columns.
Balint JP
Artif Organs; 1996 Aug; 20(8):906-13. PubMed ID: 8853805
[TBL] [Abstract][Full Text] [Related]
14. Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura.
Snyder HW; Cochran SK; Balint JP; Bertram JH; Mittelman A; Guthrie TH; Jones FR
Blood; 1992 May; 79(9):2237-45. PubMed ID: 1571540
[TBL] [Abstract][Full Text] [Related]
15. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
16. Prolonged response of chronic immune thrombocytopenic purpura (ITP) to extracorporeal immunoadsorption.
Quintini G; Barbera V; Dieli M; Marino C; Mariani G
Int J Artif Organs; 2000 Jun; 23(6):407-8. PubMed ID: 10919758
[No Abstract] [Full Text] [Related]
17. Protein A tangential flow affinity membrane cartridge for extracorporeal immunoadsorption therapy.
Jia L; Yang L; Zou H; Zhang Y; Zhao J; Fan C; Sha L
Biomed Chromatogr; 1999 Nov; 13(7):472-7. PubMed ID: 10534759
[TBL] [Abstract][Full Text] [Related]
18. Modulation of immunity in patients with autoimmune disease and cancer treated by extracorporeal immunoadsorption with PROSORBA columns.
Snyder HW; Balint JP; Jones FR
Semin Hematol; 1989 Apr; 26(2 Suppl 1):31-41. PubMed ID: 2543085
[TBL] [Abstract][Full Text] [Related]
19. Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients.
Karpatkin S; Nardi MA; Hymes KB
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2263-7. PubMed ID: 7892259
[TBL] [Abstract][Full Text] [Related]
20. Current controversies concerning the measurement of platelet-associated IgG.
Sinha RK; Kelton JG
Transfus Med Rev; 1990 Apr; 4(2):121-35. PubMed ID: 2134620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
